150
Participants
Start Date
May 27, 2021
Primary Completion Date
September 30, 2025
Study Completion Date
August 1, 2026
Zilretta Injectable Product or Placebo
The purpose of this intervention is to determine the use of extended release steroid knee injection (Zilretta) at the end of the surgery and its effects on your knee pain.In this study Zilretta will be injected intra-operatively for your arthroscopic partial meniscectomy (APM) surgery.Participants will have MRIs x-rays, and provide a sample of the synovial fluid from both knees at the beginning of surgery. This fluid is drained at the beginning of surgery and then usually discarded. Three samples each of blood and urine will be collected over the study period from each participant and sample of joint (synovial tissue) taken. Participants will be asked to answer questions about knee pain.
Cleveland Clinic Foundation, Cleveland
Bringham and Women's Hospital, Boston
Collaborators (1)
Arthritis Foundation
OTHER
The Cleveland Clinic
OTHER